BIOMARIN PHARMACEUTICAL INC — SC 13G/A Filings
124 SC 13G/A filings on record
This page lists all SC 13G/A filings submitted to the SEC by BIOMARIN PHARMACEUTICAL INC (BMRN), sorted by most recent first. Each row links to the full filing on EdgarLookup. BIOMARIN PHARMACEUTICAL INC has filed 124 SC 13G/A documents with the SEC since 2016. To view all SEC filings by BIOMARIN PHARMACEUTICAL INC, see the full filings list.
All
10-K
10-K/A
10-Q
10-Q/A
144
3
3/A
305B2
4
4/A
424B1
424B2
424B3
424B4
424B5
5
8-A12G
8-A12G/A
8-K
8-K/A
ARS
CORRESP
CT ORDER
DEF 14A
DEFA14A
DEFC14A
DEFM14A
DEFR14A
DFAN14A
EFFECT
FWP
NO ACT
POS AM
PRE 14A
PREC14A
PREM14A
PRER14A
PRRN14A
RW
S-1
S-1/A
S-3
S-3/A
S-3ASR
S-3MEF
S-8
S-8 POS
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SC TO-C
SC TO-T
SC TO-T/A
SCHEDULE 13G/A
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| SC 13G/A | SCHEDULE 13G/A | 0001104659-24-078886 | Jul 10, 2024 | — |
| SC 13G/A | — | 0001086364-24-008220 | Jul 8, 2024 | — |
| SC 13G/A | SCHEDULE 13G/A | 0001104659-24-020434 | Feb 13, 2024 | — |
| SC 13G/A | SC 13G/A | 0001193125-24-033352 | Feb 13, 2024 | — |
| SC 13G/A | PRIMECAP MANAGEMENT CO/CA/ | 0001085146-24-001100 | Feb 12, 2024 | — |
| SC 13G/A | — | 0001086364-24-004389 | Jan 26, 2024 | — |
| SC 13G/A | SC 13G/A | 0001193125-23-038468 | Feb 14, 2023 | — |
| SC 13G/A | SEC SCHEDULE 13G | 0001422848-23-000083 | Feb 13, 2023 | — |
| SC 13G/A | SCHEDULE 13G/A | 0001104659-23-015461 | Feb 9, 2023 | — |
| SC 13G/A | PRIMECAP MANAGEMENT CO/CA/ | 0001085146-23-000889 | Feb 9, 2023 | — |
| SC 13G/A | — | 0001306550-23-007857 | Feb 3, 2023 | — |
| SC 13G/A | — | 0000834237-22-009166 | Mar 11, 2022 | — |
| SC 13G/A | SC 13G/A | 0001193125-22-040793 | Feb 14, 2022 | — |
| SC 13G/A | PRIMECAP MANAGEMENT CO/CA/ | 0001085146-22-000718 | Feb 10, 2022 | — |
| SC 13G/A | SCHEDULE 13G/A | 0001104659-22-016643 | Feb 9, 2022 | — |
| SC 13G/A | SEC SCHEDULE 13G | 0001422848-22-000002 | Jan 10, 2022 | — |
| SC 13G/A | SCHEDULE 13G/A | 0001104659-21-033073 | Mar 8, 2021 | — |
| SC 13G/A | SEC SCHEDULE 13G | 0001422848-21-000127 | Feb 16, 2021 | — |
| SC 13G/A | SCHEDULE 13G/A | 0001104659-21-017581 | Feb 10, 2021 | — |
| SC 13G/A | — | 0000834237-21-007538 | Feb 5, 2021 | — |
| SC 13G/A | SC 13G/A | 0001104659-21-001878 | Jan 7, 2021 | — |
| SC 13G/A | SC 13G/A | 0001104659-20-103822 | Sep 10, 2020 | — |
| SC 13G/A | SC 13G/A | 0001422848-20-000021 | Feb 14, 2020 | — |
| SC 13G/A | SCHEDULE 13G/A | 0001104659-20-017860 | Feb 12, 2020 | — |
| SC 13G/A | SC 13G/A | 0001104659-20-019060 | Feb 12, 2020 | — |
| SC 13G/A | — | 0000834237-20-008766 | Feb 10, 2020 | — |
| SC 13G/A | — | 0001137774-20-000047 | Feb 6, 2020 | — |
| SC 13G/A | 13G AMENDED ANNUAL FILING (BMRN) | 0000053417-20-000018 | Feb 4, 2020 | — |
| SC 13G/A | SC 13G/A | 0001422848-19-000026 | Feb 14, 2019 | — |
| SC 13G/A | — | 0000215457-19-007234 | Feb 11, 2019 | — |
| SC 13G/A | — | 0000932471-19-004911 | Feb 11, 2019 | — |
| SC 13G/A | SC 13G/A | 0001104659-19-006793 | Feb 8, 2019 | — |
| SC 13G/A | — | 0001137774-19-000024 | Jan 31, 2019 | — |
| SC 13G/A | 13G AMENDED ANNUAL FILING - BMRN | 0000053417-19-000018 | Jan 31, 2019 | — |
| SC 13G/A | SC 13G/A | 0001104659-18-012373 | Feb 27, 2018 | — |
| SC 13G/A | SC 13G/A | 0001422848-18-000278 | Feb 14, 2018 | — |
| SC 13G/A | SC 13G/A | 0001140361-18-007871 | Feb 14, 2018 | — |
| SC 13G/A | — | 0000315066-18-001086 | Feb 13, 2018 | — |
| SC 13G/A | — | 0000932471-18-004802 | Feb 12, 2018 | — |
| SC 13G/A | — | 0000215457-18-005207 | Feb 8, 2018 | — |
| SC 13G/A | 13G AMENDED ANNUAL FILING - BMRN | 0000053417-18-000025 | Feb 5, 2018 | — |
| SC 13G/A | — | 0001137774-18-000022 | Jan 26, 2018 | — |
| SC 13G/A | SANDS CAPITAL MANAGEMENT, LLC SC 13GA NO. 2 12-31-2016 (BIOMARIN PHARMACEUTICAL | 0001140361-17-006778 | Feb 14, 2017 | — |
| SC 13G/A | — | 0000315066-17-001492 | Feb 14, 2017 | — |
| SC 13G/A | SC 13G/A | 0001422848-17-000027 | Feb 13, 2017 | — |
| SC 13G/A | — | 0000932471-17-001627 | Feb 10, 2017 | — |
| SC 13G/A | — | 0000215457-17-001354 | Jan 19, 2017 | — |
| SC 13G/A | SC 13G/A | 0001422848-16-000201 | Feb 16, 2016 | — |
| SC 13G/A | SANDS CAPITAL MANAGEMENT SC13GA 12-31-2015 (BIOMARIN PHARMACEUTICAL INC) | 0001140361-16-052419 | Feb 16, 2016 | — |
| SC 13G/A | — | 0000315066-16-004915 | Feb 12, 2016 | — |